ClinConnect ClinConnect Logo
Search / Trial NCT06585631

The Collaborative Care PrTNER Study

Launched by CHILDREN'S HOSPITAL OF PHILADELPHIA · Sep 3, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Gay, Bisexual Young Men Who Have Sex With Men Young Black Men Who Have Sex With Men Young Latino Men Who Have Sex With Men Hiv Aids Substance Use Substances Use Disorder Men Who Have Sex With Men Young Gay Men Gay Men Drug Use Alcohol Use Preexposure Prophylaxis Pr Ep Peer Coaches Community Health Worker Lgbt Bisexual

ClinConnect Summary

The Collaborative Care PrTNER Study is a clinical trial aimed at helping young Black and Latino men who have sex with men, aged 15 to 24, who are at risk for HIV or living with HIV. The study is testing a new approach called PrTNER, which focuses on providing support and resources to encourage these young men to start taking pre-exposure prophylaxis (PrEP) if they are at risk for HIV and to help those living with HIV reduce their viral load. Essentially, the goal is to improve their health by connecting them to the right treatments and support services.

To participate in this study, you need to be a cisgender male aged 15 to 24 who identifies as Black or Latino, has had oral or anal sex with another male, and lives in the Philadelphia or Baltimore areas. If you are at risk for HIV, you should have a history of not consistently taking PrEP or have substance use behaviors. If you are living with HIV, you should have not been taking your HIV medications as prescribed. Participants will receive support throughout the trial, and your involvement will help researchers understand how to better engage young men in these important health services.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Aim 1:
  • 15-24 years old;
  • Cisgender male;
  • Self-identified Black/African American race or Latino/Hispanic ethnicity;
  • Report prior oral/anal sex with another male;
  • At-risk for HIV (condomless anal sex or positive sexually transmitted infection (STI) in last 6 months);
  • Moderate-to-high risk SU behaviors based upon a Car, Relax, Alone, Forget, Friends, Trouble (CRAFFT) score ≥2,
  • Living in Philadelphia, PA or Baltimore, MD, and surrounding areas;
  • Able to read and write in English
  • Aim 2:
  • 15-24 years old;
  • Cisgender male;
  • Self-identified Black/African American race or Latino/Hispanic ethnicity;
  • Report prior oral/anal sex with another male;
  • Living with a diagnosis of HIV;
  • CRAFFT score ≥2,
  • Living in Philadelphia, PA or Baltimore, MD, and surrounding areas;
  • Able to read and write in English
  • Aim 3
  • • All randomized study participants will be included in Aim 3.
  • Exclusion Criteria:
  • Aim 2:
  • * Participants will be excluded if they are:
  • Assigned female sex at birth
  • Identify as transgender
  • Outside the age criteria (\<15 or \>24 years old)
  • Cognitively unable to complete study requirements
  • Living outside of the two geographic areas
  • Do not screen positive for SU
  • No prior substance use history
  • No prior oral or anal sex;
  • Unable to read or write in English,
  • Plan to move in the next 12 months.

About Children's Hospital Of Philadelphia

The Children's Hospital of Philadelphia (CHOP) is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and clinical care. As a prominent clinical trial sponsor, CHOP emphasizes a multidisciplinary approach to pediatric research, fostering collaborations across various specialties to develop and evaluate groundbreaking therapies and interventions. With a focus on improving patient outcomes and enhancing the quality of life for children, CHOP is dedicated to conducting rigorous clinical trials that adhere to the highest ethical standards and scientific integrity, ultimately contributing to the global knowledge base in pediatric medicine.

Locations

Philadelphia, Pennsylvania, United States

Baltimore, Maryland, United States

Patients applied

0 patients applied

Trial Officials

Renata Sanders, MD

Principal Investigator

Children's Hospital of Philadelphia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported